AI assistant
Sending…
ELI LILLY & Co — Director's Dealing 2010
Jan 11, 2010
29745_dirs_2010-01-11_d7ccad1c-3325-44f7-a0c3-78c5a6af08f7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2010-01-01
Reporting Person: Simmons Jeffrey N (President-Elanco Anml.Hlth. BU)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 169 | Direct |
| Common Stock | 5 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Employee stock option 10/01 (right to buy) | $79.28 | 2011-10-04 | Common Stock (1850) | Direct | |
| Employee stock option 2/01 (right to buy) | $73.98 | 2011-02-18 | Common Stock (4300) | Direct | |
| Employee stock option 2/02 (right to buy) | $75.92 | 2012-02-17 | Common Stock (4300) | Direct | |
| Employee stock option 2/03 (right to buy) | $57.85 | 2013-02-15 | Common Stock (8500) | Direct | |
| Employee stock option 2/04 (right to buy) | $73.11 | 2014-02-14 | Common Stock (10000) | Direct | |
| Employee stock option 2/05 (right to buy) | $55.65 | 2015-02-10 | Common Stock (8787) | Direct | |
| Employee stock option 2/06 (right to buy) | $56.18 | 2016-02-09 | Common Stock (9789) | Direct | |
| Restricted Stock Unit | $ | 2013-05-01 | Common Stock (10000) | Direct | |
| Restricted Stock Unit | $ | 2018-05-01 | Common Stock (20000) | Direct | |
| Restricted Stock Unit | $ | 2011-08-31 | Common Stock (3278) | Direct | |
| Restricted Stock Unit | $ | 2016-08-31 | Common Stock (6556) | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.
More from ELI LILLY & Co
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
May 1
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 29